Arcadia Biosciences Revenue, Profits - RKDA Annual Income Statement

Add to My Stocks
$9.98 $0.22 (2.16%) RKDA stock closing price May 25, 2018 (Closing)

Fundamental analysis of RKDA stock involves analyzing its financial statements, apart from checking the Arcadia Biosciences stock price. In the income statement, an investor can check for important parameters like the topline or sales, the bottomline or profits, the basic EPS, dividends etc. The income statement is generated for a specific period of time, typically a year or a quarter. The revenue increase to $4.02M for 2017 impacts the RKDA stock. Investors typically check year over year or quarter over quarter revenue growth. The Arcadia Biosciences profit and loss statement for 2017 shows a net profit of $-15.7M. Profits for last year was $-19.62M. Apart from this an investor should also check Arcadia Biosciences assets and Arcadia Biosciences free cash flow.

View revenue and profit details for latest and last 10 financial years.
show more
Fiscal year is Jan - Dec20172016201520142013
Arcadia Biosciences Revenues or Net Sales
4.02M3.18M5.41M6.98M6.47M
Cost Of Goods Sold (COGS)---1.99M-
Arcadia Biosciences Gross Profit
3.74M2.29M4.52M4.98M5.8M
Research & Development Expense7.4M8.66M8.96M10.01M8.4M
Selling General & Admin Expense10.65M12.25M11.11M10.12M7.96M
Income Before Depreciation Depletion Amortization-14.31M-18.62M-15.56M-15.15M-10.56M
Depreciation Depletion Amortization-----
Non Operating Income-0.61M---0.59M-
Interest Expense-1.31M2.65M1.39M-
Arcadia Biosciences Pretax Income
-15.68M-19.59M-17.93M-17.14M-11.18M
Provision for Income Taxes-----
MinorityInterest-----
Investment Gains Losses----0.93M-1.84M
Other Income-----
Income Before Extraordinaries & Disc Operations-15.7M-19.62M-17.95M-18.33M-13.19M
Extraordinary Items & Discontinued Operations-----
Arcadia Biosciences Profit/ Loss (Net Income)
-15.7M-19.62M-17.95M-18.33M-13.19M
Average Shares used to compute Diluted EPS2.16M2.22M1.43M--
Average Shares used to compute Basic EPS2.16M2.22M1.43M--
Income Before Nonrecurring Items-14.81M-19.62M-17.73M-18.34M-
Income from Nonrecurring Items-0.9M--0.23M--
Arcadia Biosciences Earnings Per Share Basic Net
-7.28-8.80-14.60-214.20-
Arcadia Biosciences Earnings Per Share Diluted Net
-7.28-8.80-14.60-214.20-
EPS Diluted Before Nonrecurring Items-6.86-8.80-14.40-214.20-
Preferred Dividends Acc Pd-----
Dividends Common-----
Dividend Per Share Common0.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.

Arcadia Biosciences stock analysis involves checking at least a few of the important things like:

  • Revenue: This is the inflow that is generated from the sale of goods or services and is $4.02M for this year of 2017. Our Arcadia Biosciences revenue chart gives a clear visual representation of how the topline or sales growth has been. Investors often invest only in those companies where the revenue is growing at a steady rate.
  • Bottom line: This refers to the last line in a profit and loss statement and denotes the net profit or loss for a particular period. The figure currently stands at $-15.7M for Arcadia Biosciences for 2017. This figure is arrived at after deducting all operating expenses, interest, and taxes from revenue.

The income statement is also called the profit and loss statement. Apart from the RKDA income statement, one can check the Arcadia Biosciences historical stock prices to check how the price has moved with time.

Arcadia Biosciences Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
6.79
Dividend Yield
0%